PyTDC: A multimodal machine learning training, evaluation, and inference platform for biomedical foundation models
Not on the map. Why?
Abstract (arXiv)
Existing biomedical benchmarks do not provide end-to-end infrastructure for training, evaluation, and inference of models that integrate multimodal biological data and a broad range of machine learning tasks in therapeutics. We present PyTDC, an open-source machine-learning platform providing streamlined training, evaluation, and inference software for multimodal biological AI models. PyTDC unifies distributed, heterogeneous, continuously updated data sources and model weights and standardizes benchmarking and inference endpoints. This paper discusses the components of PyTDC's architecture and, to our knowledge, the first-of-its-kind case study on the introduced single-cell drug-target nomination ML task. We find state-of-the-art methods in graph representation learning and domain-specific methods from graph theory perform poorly on this task. Though we find a context-aware geometric deep learning method that outperforms the evaluated SoTA and domain-specific baseline methods, the model is unable to generalize to unseen cell types or incorporate additional modalities, highlighting PyTDC's capacity to facilitate an exciting avenue of research developing multimodal, context-aware, foundation models for open problems in biomedical AI.
Key facts. Cited by 1 paper in the map (data through 14 Oct 2026). Builds on 30 of its 157 references that are in the map. First posted on arXiv 8 May 2025.
Builds on
30 of 157 references.
References · 30
- 2019PyTorch: An Imperative Style, High-Performance Deep Learning Librarycited by 20,305
- 2017Graph Attention Networkscited by 8,923
- 2023Toolformer: Language Models Can Teach Themselves to Use Toolscited by 4,182
- 2016node2vec: Scalable Feature Learning for Networkscited by 1,918
- 2023Gorilla: Large Language Model Connected with Massive APIscited by 1,332
- 2017MoleculeNet: A Benchmark for Molecular Machine Learningcited by 1,051
- 2021How Attentive are Graph Attention Networks?cited by 835
- 2023ChemCrow: Augmenting large-language models with chemistry toolscited by 631
- 2018DeepDTA: Deep Drug-Target Binding Affinity Predictioncited by 173
- 2024Empowering Biomedical Discovery with AI Agentscited by 118
- 2023PRODIGY: Enabling In-context Learning Over Graphscited by 98
- 2024Position: Graph Foundation Models are Already Herecited by 86
18 more
- 2021Structure-aware Interactive Graph Neural Networks for the Prediction of Protein-Ligand Binding Affinitycited by 60
- 2021HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Datacited by 49
- 2018DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequencescited by 46
- 2022TorchDrug: A Powerful and Flexible Machine Learning Platform for Drug Discoverycited by 45
- 2022Predicting Cellular Responses to Novel Drug Perturbations at a Single-Cell Resolutioncited by 45
- 2020COMPOSE: Cross-Modal Pseudo-Siamese Network for Patient Trial Matchingcited by 37
- 2019WideDTA: prediction of drug-target binding affinitycited by 30
- 2022Flashlight: Enabling Innovation in Tools for Machine Learningcited by 25
- 2024Tx-LLM: A Large Language Model for Therapeuticscited by 25
- 2019Slice-based Learning: A Programming Model for Residual Learning in Critical Data Slicescited by 23
- 2021TITAN: T Cell Receptor Specificity Prediction with Bimodal Attention Networkscited by 16
- 2017Large-scale analysis of disease pathways in the human interactomecited by 14
- 2023SPOT: Sequential Predictive Modeling of Clinical Trial Outcome with Meta-Learningcited by 13
- 2022Model Stability with Continuous Data Updatescited by 9
- 2020Cross-Modality Protein Embedding for Compound-Protein Affinity and Contact Predictioncited by 3
- 2020Managing Data Lineage of O&G Machine Learning Models: The Sweet Spot for Shale Use Casecited by 2
- 2017Neighborhood-Based Label Propagation in Large Protein Graphscited by 1
- 2023Machine Learning Techniques for Predicting the Short-Term Outcome of Resective Surgery in Lesional-Drug Resistance Epilepsycited by 1
Built on by
Citing papers per year: 2025: 1.
1 paper.